
HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $1.18 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 25.16%, resulting in a loss of $6.50 million. HTG Molecular Diagnostics collected $2.88 million in revenue during Q4, but reported earnings showed a $5.19 million loss.